- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01398488
Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education
Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education - a Randomized Open Controlled Trial
Experimental intervention:
Patient education after lung transplantation via Tablet computers. An electronic patient questionnaire via tablet computer will be collected in addition.
Control intervention:
Conventional Patient education by health care professionals. A paper-based patient questionnaire will be provided.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Noncompliance with immunosuppressive medications after organ transplantation is thought to be a leading cause of allograft rejection, graft loss, and death. Immunosuppressant medy to prevent graft rejection after lung transplantation.
Reported non-compliance rates with calcineurin inhibitors are ranging between 13 and 22 % after lung transplantation. Incidence of non-compliance increases over time after transplantation. Increased health care costs, decreased quality of life, and organ failure (incl. the need for re-do transplantation) are possible consequences of immunosuppressant noncompliance. Therefore, medication compliance defined as the extent to which a patient's medication taking behaviour coincides with the prescribed regimen, is a critical issue in transplantation. Repeated patient education is one option to overcome non-adherence and immunosuppressive medication non-compliance.
Immunosuppressive therapy is monitored by measurement of drug levels. Fluctuating drug levels increase the risk for rejection and drug toxicities. In addition, frequent dose adjustments, case management and frequent monitoring of drug levels are cost-intensive.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Lower Saxony
-
Hanover, Lower Saxony, Germany, 30625
- Hanover Medical School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients at least 6 months after lung transplantation (single, double or combined)
- Informed consent
- At least 10 trough levels analyzed in MHH reference lab in last 6 months
- < 50% of calcineurin inhibitor trough levels in target range in last 6 months in outpatient clinic
Exclusion Criteria:
- Hospitalization during last 3 months
- BOS stage 3 (FEV1 < 50% baseline)
- End stage kidney disease (GFR <15 ml/min/1.73 m2 or renal replacement therapy)
- Oxygen requirement at rest
- Steroid pulse therapy (>500 mg methylprednisolone per day) during the last 4 weeks
- Illiteracy
- Need for isolation (Colonization with multi. or pan resistant organisms, e.g. MRSA, B. cenocepacia)
- limited German language skills or other reasons which might impair patient communication or computer handling
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional Patient education
Conventional Patient education by health care professionals.
|
Patient education by health care professional compared to education via tablet PC
|
Experimental: Patient education via Tablet computer
Patient education after lung transplantation via Tablet computers.
An electronic patient questionnaire via tablet computer will be collected in addition.
|
Patient education by health care professional compared to education via tablet PC
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Calcineurin trough levels
Time Frame: 6 month
|
Improvement of percentage of calcineurin inhibitor trough levels (Delta %) in target range 6 months after patient education compared to 6 months before patient education
|
6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Calcineurin trough levels variability
Time Frame: 6 month
|
Trough level variability 6 months after patient education compared to 6 months before patient education
|
6 month
|
Interval Adherence
Time Frame: 6 month
|
interval adherence (number of measurements vs. recommended measurements) 6 months after patient education compared to 6 months before patient education
|
6 month
|
Trough level interval
Time Frame: 6 month
|
Interval of trough level measurement variability 6 months after patient education compared to 6 months before patient education
|
6 month
|
Total time of education
Time Frame: 6 month
|
Total time of education
|
6 month
|
Total time of answering questionnaire
Time Frame: 6 month
|
Total time of answering questionnaire
|
6 month
|
Knowledge Improvement
Time Frame: 6 month
|
Improvement of patient knowledge on immunosuppressive after patient education
|
6 month
|
Self rated adherence
Time Frame: 6 month
|
Self rated adherence to immunosuppressive medication (BAASIS scale)
|
6 month
|
Adherence
Time Frame: 6 month
|
Therapy adherence 6 months after patient education compared to 6 months before patient education
|
6 month
|
Glomerular filtration rate
Time Frame: 6 month
|
Glomerular filtration rate 6 months after patient education compared to baseline (CKD-EPI)
|
6 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jens T Gottlieb, MD, Hannover Medical School
Publications and helpful links
General Publications
- Mellon L, Doyle F, Hickey A, Ward KD, de Freitas DG, McCormick PA, O'Connell O, Conlon P. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients. Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2.
- Suhling H, Rademacher J, Zinowsky I, Fuge J, Greer M, Warnecke G, Smits JM, Bertram A, Haverich A, Welte T, Gottlieb J. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS One. 2014 Mar 7;9(6):e90828. doi: 10.1371/journal.pone.0090828. eCollection 2014.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- V 2.0 16/03/2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Transplantation
-
Astellas Pharma Europe Ltd.Active, not recruitingLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine TransplantationBelgium, Czechia, France, Germany, Italy, Poland, United Kingdom
-
Emory UniversityCompletedLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Heart-Lung TransplantationUnited States
-
Astellas Pharma IncCompletedHeart Transplantation | Lung Transplantation | Pancreas (Including SPK) TransplantationFrance, United Kingdom, Taiwan, Belgium, Italy, Austria
-
Hannover Medical SchoolUnknownExercise Training | Lung Transplantation | Psychotherapy | Heart-Lung Transplantation | "Rehabilitation"Germany
-
University of AlbertaNatera, Inc.; One LambdaRecruiting
-
Universidad Complutense de MadridHospital Universitario 12 de OctubreRecruiting
-
KU LeuvenCompleted
-
Hopital FochCompleted
-
Emory UniversityTerminated
-
Hannover Medical SchoolCorscience, Inc.CompletedLung TransplantationGermany
Clinical Trials on Patient education
-
University Hospital, MontpellierCompleted
-
Riphah International UniversityCompleted
-
Chulabhorn HospitalCompletedSurgery | Educational Problems
-
University of VictoriaVancouver FoundationCompletedDiabetes Mellitus, Type 2Canada
-
Children's Hospital of PhiladelphiaMidwestern UniversityCompletedInformed Consent | Procedural State Anxiety | Subject's SatisfactionUnited States
-
University of MalayaCompletedPressure Injury | Limitation, MobilityMalaysia
-
Trakya UniversityCompletedPain | Pain Management | Fear of Pain | Patient EducationTurkey
-
Riphah International UniversityCompletedPulmonary Arterial HypertensionPakistan
-
Aarhus University HospitalNovo Nordisk A/S; TrygFonden, Denmark; Aalborg University Hospital; Horsens Hospital and other collaboratorsActive, not recruitingRheumatoid Arthritis | Self Efficacy | Patient InvolvementDenmark